Mankind Pharma prescription share: Proven growth with 50 US products
Mankind Pharma prescription share is growing, reporting a 15.2% share as it launches 50 products…
Category: pharma
Provider Growth Strategy: Proven Path to Success
Provider growth strategy is key for healthcare success. Discover how Sagility's acquisition of Chirok Health…
Cancer drug price cap: Is it the best move for patients?
Cancer drug price cap leads to a 70% reduction in costs, benefiting patients. Discover how…
Drug price caps: The Wrong Approach to Cancer Treatment
Drug price caps are crucial, but the focus must extend beyond cancer drugs for better…
Cancer drug prices may fall: A clear path to affordability
Cancer drug prices may soon drop significantly, making treatments more accessible for patients.
FDA Approval News: Is ANI Pharmaceuticals Undervalued?
FDA approval news reveals if ANI Pharmaceuticals is truly undervalued by 31%.
Drug price disparity: What is the real impact on patients?
Drug price disparity highlights the challenges patients face in Karnataka's healthcare system.
Is Lantheus Bravnetsa Approval a Safe and Proven Option?
Lantheus Bravnetsa approval marks a significant advancement in treatment options. Discover its implications and benefits.
FDA Approval Delay: What It Means for Colorectal Cancer Patients
FDA approval delay impacts treatment options for colorectal cancer.
Bayer lung cancer drug approval: Safe and Proven Solution
Bayer lung cancer drug approval expands treatment options for patients.